REPLICATE
Live / Registered — Registered (as of 22 Sept 2026)
What this means for you
Registered since 22 Sept 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 22 Sept 2032: the §8 declaration of use).
Record
- Serial number
- 97157972
- Registration number
- 8450965
- Mark type
- Word mark
- Filed
- 06 Dec 2021
- Published for opposition
- 21 Mar 2023
- Registered
- 22 Sept 2026
- Next maintenance filing
- §8 declaration of use, due by 22 Sept 2032 (grace period to 22 Mar 2033)
- Attorney of record
- Karen Won
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and biologic preparations for the treatment of inflammatory disorders and diseases, and infectious disorders and diseases; Biological compounds being a component in vaccines; Therapeutic agents and immunotherapies for the treatment of inflammatory diseases, and infectious diseases; Biological compound for medical use, namely, self-replicating RNAs delivered into patient cells for creating therapeutic proteins; Therapeutic agents for generating or evading protective immune response
- Class 042 — Scientific and technological services: Research and development services in the fields of self-replicating RNAs, RNA therapeutics, pharmaceuticals, biologics, therapeutic proteins, inflammatory diseases, and infectious diseases; Providing medical scientific information in the fields of self-replicating RNAs, RNA therapeutics, pharmaceuticals, biologics, therapeutic proteins, inflammatory diseases, and infectious diseases
Owner
- Replicate Bioscience, Inc., San Diego, CA, US
- Replicate Bioscience, Inc., San Diego, CA, US
- Replicate Bioscience, Inc., San Diego, CA, US
Prosecution history
- 22 Sept 2026 — REGISTERED-PRINCIPAL REGISTER
- 03 Sept 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 03 Sept 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 25 Aug 2026 — ASSIGNED TO EXAMINER
- 01 May 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 27 Apr 2026 — USE AMENDMENT FILED
- 27 Apr 2026 — TEAS STATEMENT OF USE RECEIVED
- 21 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Nov 2025 — SOU EXTENSION 5 GRANTED
- 13 Nov 2025 — SOU EXTENSION 5 FILED
- 14 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 16 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 May 2025 — SOU EXTENSION 4 GRANTED
- 15 May 2025 — SOU EXTENSION 4 FILED
- 15 May 2025 — SOU TEAS EXTENSION RECEIVED